Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease

Shigeru Kiryu1, Keiichi Dodanuki, Hidemasa Takao

  • 1Department of Radiology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. kiryu-tky@umin.ac.jp

Abstract

Insights

Free-breathing diffusion-weighted MR imaging (DWI) effectively assesses Crohn's disease activity. This non-invasive technique shows high accuracy, particularly in the small bowel, with apparent diffusion coefficient (ADC) aiding quantitative analysis.

Area of Science:

  • Gastroenterology
  • Radiology
  • Medical Imaging

Background:

  • Crohn's disease is a chronic inflammatory bowel disease requiring accurate assessment of disease activity.
  • Current imaging modalities may involve contrast agents or radiation, necessitating alternative diagnostic tools.

Purpose of the Study:

  • To evaluate the utility of free-breathing diffusion-weighted magnetic resonance imaging (DWI) for assessing Crohn's disease activity.
  • To determine the diagnostic accuracy of DWI in identifying active inflammation in the bowel.

Main Methods:

  • Thirty-one Crohn's disease patients underwent free-breathing DWI without contrast agents.
  • Disease activity was assessed visually, and apparent diffusion coefficient (ADC) values were quantitatively measured in bowel segments.
  • Conventional barium studies or surgical findings served as the gold standard for comparison.

Main Results:

  • Visual assessment of DWI demonstrated high sensitivity (86.0%), specificity (81.4%), and accuracy (82.4%) for detecting active Crohn's disease segments.
  • Quantitative analysis revealed significantly lower ADC values in disease-active bowel segments compared to inactive segments in both small and large bowels (P<0.001).

Conclusions:

  • Free-breathing DWI is a valuable tool for assessing Crohn's disease activity.
  • The technique offers high diagnostic accuracy, especially for small bowel involvement.
  • Apparent diffusion coefficient (ADC) measurements provide a quantitative method to evaluate disease activity in Crohn's disease.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...